Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
- PMID: 2960611
- PMCID: PMC1453988
Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells
Abstract
Murine lymphocytes have been shown previously to possess high-affinity specific receptors for the neuropeptide vasoactive intestinal peptide (VIP). This study examines the cellular basis for modulation of concanavalin A (Con A)-induced T-cell responses by this neuropeptide. VIP was most effective as an inhibitor when added at the initiation of the mitogen response. The loss of potency when VIP was added later in the response was accompanied by a decrease in the affinity of stimulated cells for the neuropeptide. The inhibitory influence of VIP was reversible if the neuropeptide was removed from stimulated cell cultures up to 6 hr after the initiation of stimulation. In contrast, VIP-mediated inhibition was fully developed once the stimulated cells had been exposed to the neuropeptide for 24 hr. The presence of VIP led to a decreased production of interleukin-2 (IL-2) by the stimulated lymphocytes, but did not affect the expression of Con A-induced suppressor cell activity by cultured lymphocytes. Studies of the effect of selective, complement-mediated killing of cells with Thy 1, L3T4 and Lyt 2 monoclonal antibodies showed that the majority of the VIP bound by the lymphocytes was accounted for by binding to L3T4+, Lyt 2- T cells. It was concluded that VIP exerts its influence over Con A-stimulated proliferation by selective regulation of T-cell subsets.
Similar articles
-
Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.Cell Immunol. 1993 Jun;149(1):11-23. doi: 10.1006/cimm.1993.1132. Cell Immunol. 1993. PMID: 8099848
-
Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.J Neurosci Res. 1991 May;29(1):29-41. doi: 10.1002/jnr.490290104. J Neurosci Res. 1991. PMID: 1653367
-
Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.J Immunol. 1984 Jan;132(1):417-23. J Immunol. 1984. PMID: 6606671
-
Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.J Immunol. 1992 Jun 1;148(11):3572-7. J Immunol. 1992. PMID: 1588046
-
VIP modulation of immune cell functions.Adv Neuroimmunol. 1996;6(1):75-91. doi: 10.1016/s0960-5428(96)00002-2. Adv Neuroimmunol. 1996. PMID: 8790783 Review.
Cited by
-
Vasoactive intestinal peptide induces S(alpha)/S(mu) switch circular DNA in human B cells.J Clin Invest. 1996 Oct 1;98(7):1527-32. doi: 10.1172/JCI118944. J Clin Invest. 1996. PMID: 8833899 Free PMC article.
-
Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes.Immunology. 1989 Apr;66(4):554-8. Immunology. 1989. PMID: 2654011 Free PMC article.
-
VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.Mol Neurobiol. 1995 Apr-Jun;10(2-3):115-34. doi: 10.1007/BF02740671. Mol Neurobiol. 1995. PMID: 7576303 Review.
-
Without nerves, immunology remains incomplete -in vivo veritas.Immunology. 2005 Oct;116(2):145-63. doi: 10.1111/j.1365-2567.2005.02223.x. Immunology. 2005. PMID: 16162264 Free PMC article. Review.
-
Cloning and expression of the human vasoactive intestinal peptide receptor.Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4986-90. doi: 10.1073/pnas.88.11.4986. Proc Natl Acad Sci U S A. 1991. PMID: 1675791 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases